Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

71%

Beneficial ownership of this reported class.

Shares

312,518,088 shares

Shares beneficially owned as disclosed.

Event date

15 Apr 2026

Date tied to the ownership event or amendment.

Accepted by SEC

17 Apr 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
TRI
Shares outstanding
442,911,122 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
17 Apr 2026, 21:20:42 UTC
Event date
15 Apr 2026
Prior SEC filing
10 Nov 2025
Source filing
View source filing

Key filing fact

Woodbridge CO LTD disclosed 71% ownership in THOMSON REUTERS CORP /CAN/ Common Shares of Thomson Reuters Corporation (TRI) on 15 Apr 2026.

Key facts

  • Woodbridge CO LTD filed SCHEDULE 13D/A for THOMSON REUTERS CORP /CAN/ Common Shares of Thomson Reuters Corporation (TRI).
  • Disclosed ownership: 71%.
  • Date of event: 15 Apr 2026.

Change

  • Previous schedule filing date: 10 Nov 2025.
  • Current filing was accepted on 17 Apr 2026, 21:20.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (42)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
THOMSON INVESTMENTS LIMITED 71% 312,518,088 0 312,518,088 /s/ Michael Medline CEO & President
THE WOODBRIDGE COMPANY LIMITED 68% 300,790,959 0 300,790,959 /s/ Michael Medline CEO & President 0001397960
1908720 ONTARIO LIMITED 46% 202,322,148 0 202,322,148 /s/ Michael Medline CEO & President
1000706525 ONTARIO LIMITED 19% 84,798,839 0 84,798,839 /s/ Michael Medline CEO & President
1396164 Ontario Limited 2.9% 13,160,949 0 13,160,949 /s/ Michael Medline CEO & President
1925124 Ontario Limited 0.1% 506,720 0 506,720 /s/ Michael Medline CEO & President
Woodbridge Investments Corporation 0% 2,303 0 2,303 /s/ Michael Medline CEO & President
KRT INVESTMENTS CORP. 0% 87,754 0 87,754 /s/ Michael Medline Attorney-in-fact
DKRT FAMILY CORP. 0% 276,864 0 276,864 /s/ Michael Medline Attorney-in-fact
DKRT INVESTMENTS CORP. 0.1% 327,761 0 327,761 /s/ Michael Medline Attorney-in-fact
DKRT FUNDING CORP. 0% 137,630 0 137,630 /s/ Michael Medline Attorney-in-fact
1000920847 ONTARIO LIMITED 0.1% 260,000 0 260,000 /s/ Michael Medline Attorney-in-fact
MB FINANCE CORP. 0% 1,596 0 1,596 /s/ Michael Medline Attorney-in-fact
TT INVESTMENTS CORP. 0% 16,516 0 16,516 /s/ Michael Medline Attorney-in-fact
TLT INVESTMENTS CORP. 0.12% 530,176 0 530,176 /s/ Michael Medline Attorney-in-fact
TLT ISSUE HOLDCO A CORP. 0% 195,900 0 195,900 /s/ Michael Medline Attorney-in-fact
TLT ISSUE HOLDCO CORP. 0.17% 759,751 0 759,751 /s/ Michael Medline Attorney-in-fact
1761173 ONTARIO LIMITED 0.32% 1,422,190 0 1,422,190 /s/ Michael Medline Attorney-in-fact
2677295 ONTARIO LIMITED 0.16% 697,006 0 697,006 /s/ Michael Medline Attorney-in-fact
1000919995 ONTARIO LIMITED 0.1% 260,000 0 260,000 /s/ Michael Medline Attorney-in-fact
1754693 ONTARIO LIMITED 0.1% 437,878 0 437,878 /s/ Michael Medline Attorney-in-fact
PJT INVESTMENTS CORP. 0.1% 270,297 0 270,297 /s/ Michael Medline Attorney-in-fact
1000920848 ONTARIO LIMITED 0.1% 260,000 0 260,000 /s/ Michael Medline Attorney-in-fact
PGF INVESTMENTS CORP. 0% 20,358 0 20,358 /s/ Michael Medline Attorney-in-fact
PGF FAMILY CORP. 0% 19,984 0 19,984 /s/ Michael Medline Attorney-in-fact
LCC INVESTMENTS CORP. 0.4% 1,777,670 0 1,777,670 /s/ Michael Medline Attorney-in-fact
1000078931 ONTARIO LIMITED 0.1% 357,105 0 357,105 /s/ Michael Medline Attorney-in-fact
1000421133 ONTARIO LIMITED 0% 39,832 0 39,832 /s/ Michael Medline Attorney-in-fact
LLD INVESTMENTS CORP. 0% 96,804 0 96,804 /s/ Michael Medline Attorney-in-fact
2806335 ONTARIO LIMITED 0% 64,585 0 64,585 /s/ Michael Medline Attorney-in-fact
JRD INVESTMENTS CORP. 0.1% 412,843 0 412,843 /s/ Michael Medline Attorney-in-fact
2754783 ONTARIO LIMITED 0% 6,988 0 6,988 /s/ Michael Medline Attorney-in-fact
GED INVESTMENTS CORP. 0.1% 485,738 0 485,738 /s/ Michael Medline Attorney-in-fact
SEG INVESTMENTS CORP. 0.1% 477,059 0 477,059 /s/ Michael Medline Attorney-in-fact
1000031857 ONTARIO LIMITED 0.1% 444,575 0 444,575 /s/ Michael Medline Attorney-in-fact
SEG FAMILY CORP. 0% 66,546 0 66,546 /s/ Michael Medline Attorney-in-fact
TCM INVESTMENTS CORP. 0.1% 268,255 0 268,255 /s/ Michael Medline Attorney-in-fact
DYM INVESTMENTS CORP. 0.1% 254,129 0 254,129 /s/ Michael Medline Attorney-in-fact
BG INVESTMENTS CORP. 0.1% 521,530 0 521,530 /s/ Michael Medline Attorney-in-fact
ACG INVESTMENTS CORP. 0.1% 233,236 0 233,236 /s/ Michael Medline Attorney-in-fact
1001404651 ONTARIO LIMITED 0% 1,513 0 1,513 /s/ Michael Medline Attorney-in-fact
2808194 ONTARIO LIMITED 0.1% 237,060 0 237,060 /s/ Michael Medline Attorney-in-fact
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .